Elevance Health (ELV) Receivables - Other (2009 - 2026)

Elevance Health (ELV) has reported Receivables - Other for 18 consecutive years, with $6.8 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Other fell 5.38% year-over-year to $6.8 billion in Q2 2026; TTM through Jun 2026 was $6.8 billion, a 5.38% decrease from a year earlier, with the FY2025 full-year figure at $6.3 billion, up 4.84% from the prior year.
• Receivables - Other was $6.8 billion for Q2 2026 at Elevance Health, up from $6.2 billion in the prior quarter.
• Over five years, Receivables - Other peaked at $7.7 billion in Q3 2025 and troughed at $3.3 billion in Q1 2022.
• A 5-year average of $5.5 billion and a median of $5.6 billion in 2023 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other surged 44.97% in 2023 and dropped 6.22% in 2026, its largest moves.
• Over 5 years, Receivables - Other stood at $4.3 billion in 2022, then gained by 25.76% to $5.4 billion in 2023, then advanced by 11.3% to $6.0 billion in 2024, then advanced by 4.84% to $6.3 billion in 2025, then advanced by 8.1% to $6.8 billion in 2026.
• The last three Receivables - Other figures came in at $6.8 billion (Q2 2026), $6.2 billion (Q1 2026), and $6.3 billion (Q4 2025), per Business Quant data.